Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 431 publications
Clinical Efficacy and Real-World Effectiveness of Fabry Disease Treatments: A Systematic Literature Review.
Journal: Journal of clinical medicine
Published: May 23, 2025
Progress and Challenges in the Treatment of Fabry Disease.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: April 09, 2025
Correction to "Clinical Outcomes in Patients Switching From Agalsidase Beta to Migalastat: A Fabry Registry Analysis".
Journal: Journal of inherited metabolic disease
Published: March 25, 2025
Unexpected Hypotension in a Female Patient with Fabry Disease: Switching from Agalsidase α to β after Long-term ERT.
Journal: Internal medicine (Tokyo, Japan)
Published: February 09, 2025
Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapy.
Journal: Molecular genetics and metabolism reports
Published: January 22, 2025
A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease.
Journal: Orphanet journal of rare diseases
Published: January 15, 2025
Current treatment status of fabry disease in South Korea: a longitudinal National health insurance service data-based study.
Journal: Orphanet journal of rare diseases
Published: January 07, 2025
New Drugs Available for Fabry Disease.
Journal: Kidney & blood pressure research
Published: December 30, 2024
A real-world pharmacovigilance analysis for agalsidase beta: findings from the FDA adverse event reporting database.
Journal: Expert opinion on drug safety
Published: December 21, 2024
A 1-Bag/4-Step Rapid Desensitization Protocol to Reintroduce Agalsidase α in a Patient With Fabry Disease.
Journal: Journal of investigational allergology & clinical immunology
Published: December 02, 2024
Efforts of the Pharmaceuticals and Medical Devices Agency of Japanese regulatory agency in supporting biosimilar development and disseminate information.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: November 15, 2024
Adequate hemodialysis does not compromise the cardioprotective effect of agalsidase alfa on patients with Fabry disease: a case report.
Journal: Journal of medical case reports
Published: November 06, 2024
Last Updated: 10/31/2025